Clinical Trials Browser

Phase 1 × icotinib × Gastrointestinal × Clear all

NCT02278458 2015-05-22

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

Phase 1 Unknown

Gastrointestinal

Pancreatic Neoplasms